CA

Chinmay Anirudha Patwardhan

Active Director Designated Partner DIN 09177450
DIN 09177450 First appointment May 2021 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Chinmay Anirudha Patwardhan

Data last updated:

Chinmay Anirudha Patwardhan is a Designated Partner at Curem Biotech Llp (since 2021). The company operates in Research & Development.

DIN 09177450
Primary Designation Designated Partner
Industry Research & Development
First Appointment 18 May 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 May 20212021Active

Board colleagues of Chinmay Anirudha Patwardhan

NameDINCompanyDesignation
Tumuluri Sadasivam Vinayak10338223Curem Biotech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Curem Biotech Llp
Premium access

Shareholding and investment profile for Chinmay Anirudha Patwardhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chinmay Anirudha Patwardhan

Chinmay Anirudha Patwardhan currently holds 1 directorship: Curem Biotech Llp (Designated Partner, since 18 May 2021).

Chinmay Anirudha Patwardhan was first appointed on 18 May 2021 as Designated Partner at Curem Biotech Llp.

The current boards of Chinmay Anirudha Patwardhan's companies include Tumuluri Sadasivam Vinayak (Curem Biotech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available